Zikani Therapeutics (Series A-1)
Funding Details
- Awarder
- Inbox
- Date Award
- April 21, 2020
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $7,500,000
Company Info
- Founders
- Sumit Aggarwal
- Company Description
- Zikani Therapeutics is a new anti-infective company founded to advance groundbreaking technology.
- Market
- Therapeutics for rare diseases and cancers
- Location
- Watertown, MA, USA
- Coinvestors
- Advent Life Sciences, Gurnet Point Capital, Roche Venture Fund